Diagnosing Variable Primary Aldosteronism.
NCT05765786 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-06-08
Summary
The goal of this observational study is to see if there is a cyclical or exaggerated diurnal variation in aldosterone production in people with Primary Aldosteronism.
Conditions
- Primary Aldosteronism
- High Blood Pressure
Sponsors & Collaborators
-
Queen Mary University of London
lead OTHER
Principal Investigators
-
William Drake, Prof · Queen Mary University of London
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-24
- Primary Completion
- 2026-02-24
- Completion
- 2026-02-24
Countries
- United Kingdom
Study Locations
More Related Trials
-
Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension
NCT05925569 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Plasma Metabolomics Profiling of Primary Aldosteronism
NCT06500000 ·Status: COMPLETED
-
Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment
NCT01728493 ·Status: COMPLETED
-
Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism
NCT07137364 ·Status: RECRUITING
-
The Effect of SAAE on Vascular Endothelial Function in PA Patients
NCT05561361 ·Status: RECRUITING
-
Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism
NCT04409431 ·Status: RECRUITING ·Phase: NA
-
Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study
NCT05030545 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of SAAE on Ventricular Remodeling in PA Patients
NCT05501080 ·Status: RECRUITING ·Phase: NA
-
Steroids-Based Screening for Primary Aldosteronism
NCT06941116 ·Status: RECRUITING
-
Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
NCT04761354 ·Status: COMPLETED
-
Diagnostic Accuracy of Seated Saline Suppression Test for Primary Aldosteronism
NCT03500120 ·Status: COMPLETED
-
RAS Blockade at Bedtime Versus on Awakening for Aldosterone Breakthrough
NCT01805362 ·Status: COMPLETED ·Phase: NA
-
New Screening and Diagnostic Cut-off Points of PA Patients
NCT06571084 ·Status: RECRUITING
-
Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT01853553 ·Status: COMPLETED ·Phase: PHASE3
-
Spatial Proteomics Profiles of Aldosterone-producing Adenoma and Unilateral Hyperplasia
NCT05927961 ·Status: UNKNOWN
-
Aldosterone Renin Ratio (ARR) Test to Increase Case-detection of Primary Aldosteronism (PA)
NCT05757076 ·Status: COMPLETED
-
Super Selective Adrenal Artery Embolization for Primary Aldosteronism: a Prospective Cohort Study(SAAE-PA)
NCT06513676 ·Status: RECRUITING
-
The Long-term Effect of SAAE and Medical Treatment for Primary Aldosteronism
NCT05262660 ·Status: UNKNOWN
-
Adrenal Artery Ablation Treats Primary Aldosteronism
NCT03398785 ·Status: COMPLETED ·Phase: PHASE3
-
Outcome of Patients With Primary Aldosteronism
NCT04428827 ·Status: UNKNOWN
-
Is the Evolution of the Aldosterone-renin Ratio Pre- Versus Post-operative on Day 1 Following Unilateral Adrenalectomy for Primary Hyperaldosteronism Predictive of Blood Pressure Outcomes
NCT07110155 ·Status: NOT_YET_RECRUITING
-
Calcium Channel Blockade in Primary Aldosteronism
NCT04179019 ·Status: COMPLETED ·Phase: PHASE2
-
Aldosterone and Vascular Disease in Diabetes Mellitus
NCT00214825 ·Status: COMPLETED ·Phase: NA
-
Inhibition of Aldosterone in Patients With Chronic Renal Disease
NCT00430924 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Adrenal Artery Ablation and Adrenalectomy in Patients With Primary Aldosteronism
NCT04269928 ·Status: COMPLETED